Multiple sclerosis is a chronic immune-mediated disease of the brain and spinal cord resulting in physical and cognitive impairment in young adults. It is hypothesized that a disrupted bacterial and viral gut microbiota is a part of the pathogenesis mediating disease impact through an altered gut microbiota-brain axis. The aim of this study is to …
Continue reading The gut microbiota in multiple sclerosis varies with disease activity
Small intestine motility and its ensuing flow of luminal content impact both nutrient absorption and bacterial growth. To explore this interdependence we introduce a biophysical description of intestinal flow and absorption. Rooted in observations of mice we identify the average flow velocity as the key control of absorption efficiency and bacterial growth, independent of the …
Continue reading Changing Flows Balance Nutrient Absorption and Bacterial Growth along the Gut
Highlights•Modifications of behavior and inflammatory factors in mice gut-brain axis.•Key role of gut microbiota during the different developmental phases of ASD.•Fecal microbiota transplant improves ASD symptoms.AbstractAutism spectrum disorder (ASD) is a neurodevelopmental disorder displaying the modification of complex human behaviors, characterized by social interaction impairments, stereotypical/repetitive activities and emotional dysregulation. In this study, fecal microbiota …
Establishing early diversityHumans living an urbanized lifestyle in industrialized countries tend to have less diverse microbiota than people living more rural existences. Using fecal 16S ribosomal RNA sequencing, Olm et al. found that after the first 6 months of life, the microbiome of infants living in contrasting environments diverged from Bifidobacteria-dominated assemblages. Deep metagenomic sequencing …
Continue reading Robust variation in infant gut microbiome assembly across a spectrum of lifestyles
A promising new treatment approach for major depressive disorder (MDD) targets the microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions affected in MDD. This is the first randomized controlled trial to determine whether short-term, high-dose probiotic supplementation reduces depressive symptoms along with gut microbial and neural changes in depressed patients. Patients with …
2Medical.News 